(Q44120468)

30 November 2017

title

An evaluation of level of oxidative stress and protein glycation in nondiabetic undialyzed chronic renal failure patients (English)

1 reference

30 November 2017

N Selvaraj

1

1 reference

30 November 2017

Zachariah Bobby

2

1 reference

30 November 2017

Ashok Kumar Das

3

1 reference

30 November 2017

R Ramesh

4

1 reference

30 November 2017

Bidhan Chandra Koner

5

1 reference

30 November 2017

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

324

1 reference

30 November 2017

issue

1-2

1 reference

30 November 2017

page(s)

45-50

1 reference

Free radicals as mediators of tissue injury and disease

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

Involvement of reactive oxygen species in kidney damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

Advanced glycation end products: a Nephrologist's perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

The effect of delta-gluconolactone, an oxidised analogue of glucose, on the nonenzymatic glycation of human and rat haemoglobin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

'Carbonyl stress' and dialysis-related amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

Relevance of oxidative and carbonyl stress to long-term uremic complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

Mechanisms for the formation of glycoxidation products in end-stage renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

Plasma protein thiol oxidation and carbonyl formation in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

The relative extent of glycation of haemoglobin and albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

Albumin is the major plasma protein target of oxidant stress in uremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900211-5

10.1016/S0009-8981(02)00211-5

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference